| P50 | author | Firas Kobeissy | Q56989716 |
| | Kevin K W Wang | Q37837051 |
| P2093 | author name string | Yehia Mechref | |
| | Rui Zhu | |
| | Zhiqun Zhang | |
| | Amaly Nokkari | |
| | Muhieddine Itani | |
| | Mark S. Gold | |
| | Tarek H. Mouhieddine | |
| | Mohammed Mouhieddine | |
| P2860 | cites work | Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria | Q58330323 |
| | Synapsin II and calcium regulate vesicle docking and the cross-talk between vesicle pools at the mouse motor terminals | Q60639342 |
| | Striatal dopamine nerve terminal markers in human, chronic methamphetamine users | Q71101916 |
| | 14-3-3 proteins on the MAP | Q72139467 |
| | Cyclosporine-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats | Q72186100 |
| | Priming of PC12 cells for semiquantitative microinjection studies involving Ras | Q73851137 |
| | Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics | Q83564009 |
| | Synaptic plasticity and addiction | Q22337221 |
| | Purification and identification of secernin, a novel cytosolic protein that regulates exocytosis in mast cells | Q24530089 |
| | Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats | Q24629780 |
| | Nitric oxide and peroxynitrite in health and disease | Q24645400 |
| | Methamphetamine toxicity and messengers of death | Q24647617 |
| | STRING 8--a global view on proteins and their functional interactions in 630 organisms | Q24656073 |
| | Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo | Q24685647 |
| | Mass spectrometry for translational proteomics: progress and clinical implications | Q26995497 |
| | The Microtubule Regulatory Protein Stathmin Is Required to Maintain the Integrity of Axonal Microtubules in Drosophila | Q27311512 |
| | Large-scale analysis of the yeast proteome by multidimensional protein identification technology | Q28131778 |
| | Mass spectrometry-based proteomics | Q28182890 |
| | Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray | Q28235811 |
| | Major physical and psychological harms of methamphetamine use | Q28274034 |
| | Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach | Q28276398 |
| | Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist | Q28281644 |
| | DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats | Q28282257 |
| | Neuroproteomics in neurotrauma | Q28299064 |
| | Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons | Q28376564 |
| | Effects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the rat | Q28478597 |
| | Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells | Q40422038 |
| | Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity. | Q40498060 |
| | Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity | Q40698227 |
| | Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway | Q40731614 |
| | Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis | Q41154412 |
| | Genetic inactivation of pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum. | Q42474113 |
| | Deletion of synapsins I and II genes alters the size of vesicular pools and rabphilin phosphorylation | Q42498274 |
| | Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase | Q42552381 |
| | Kainic acid induces early and transient autophagic stress in mouse hippocampus | Q42875265 |
| | A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. | Q43130663 |
| | Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats | Q43629669 |
| | Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex | Q43693008 |
| | Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons | Q43736886 |
| | The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats. | Q43794877 |
| | Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity | Q43893577 |
| | Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure | Q44071037 |
| | Screening and identification of dynamin-1 interacting proteins in rat brain synaptosomes | Q44290535 |
| | Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain | Q44345617 |
| | Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis | Q44398440 |
| | Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases | Q44727052 |
| | Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades | Q44760486 |
| | Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003). | Q44915720 |
| | Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats | Q45019476 |
| | Similarities between methamphetamine toxicity and proteasome inhibition. | Q45149968 |
| | alphaII-spectrin is essential for assembly of the nodes of Ranvier in myelinated axons. | Q46167517 |
| | Role of the NMDA receptor and nitric oxide in memory reconsolidation of cocaine-induced conditioned place preference in mice | Q46258401 |
| | Enhanced synaptic vesicle traffic in hippocampus of phenytoin-resistant kindled rats | Q46326706 |
| | Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors | Q46381667 |
| | Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthe | Q46582610 |
| | Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury | Q46672661 |
| | Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization | Q46696731 |
| | Proteomic analysis of methamphetamine-induced reinforcement processes within the mesolimbic dopamine system | Q46750445 |
| | A GSTP1 functional variant associated with cocaine dependence in a Brazilian population. | Q46793040 |
| | Brain serotonin transporter density and aggression in abstinent methamphetamine abusers | Q46876473 |
| | Methamphetamine-induced spectrin proteolysis in the rat striatum | Q46897500 |
| | Identification of morphine-6-glucuronide in chromaffin cell secretory granules. | Q46909909 |
| | Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain | Q46975553 |
| | Mapping brain size and cortical gray matter changes in elderly depression | Q47208197 |
| | Proteomic profile of differentially expressed proteins in the medial prefrontal cortex after repeated cocaine exposure | Q48093562 |
| | Hyperammonemia causes protein oxidation and enhanced proteasomal activity in response to mitochondria-mediated oxidative stress in rat primary astrocytes | Q48181312 |
| | Orbitofrontal cortex and cognitive-motivational impairments in psychostimulant addiction: evidence from experiments in the non-human primate | Q48388581 |
| | Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure | Q48450233 |
| | Protein expression profile in the striatum of acute methamphetamine-treated rats. | Q48520973 |
| | Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA) | Q48594989 |
| | Effect of prenatal methamphetamine exposure and challenge dose of the same drug in adulthood on epileptiform activity induced by electrical stimulation in female rats. | Q48880068 |
| | Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex | Q48951476 |
| | Up-regulation of protein tyrosine nitration in methamphetamine-induced neurotoxicity through DDAH/ADMA/NOS pathway. | Q51070555 |
| | Mixtures of 3,4-methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non-cytotoxic concentrations. | Q51218198 |
| | Comparability of neuropsychological test profiles in patients with chronic substance abuse and mild traumatic brain injury. | Q51899404 |
| | Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study | Q57603376 |
| | Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus | Q38028344 |
| | Mass spectrometry-based identification of proteins interacting with nucleic acids | Q38141608 |
| | Distinct effects of methamphetamine on autophagy-lysosome and ubiquitin-proteasome systems in HL-1 cultured mouse atrial cardiomyocytes | Q39112503 |
| | Two-dimensional difference gel electrophoresis | Q39792303 |
| | 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer. | Q39866694 |
| | Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells | Q40082382 |
| | Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death | Q40208468 |
| | Phosphorylation of a threonine unique to the short C-terminal isoform of betaII-spectrin links regulation of alpha-beta spectrin interaction to neuritogenesis | Q40211489 |
| | Identification and characterization of PEBP as a calpain substrate | Q40224274 |
| | The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology | Q28504513 |
| | SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release | Q28512897 |
| | Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity | Q28565510 |
| | Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury | Q28568228 |
| | Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity | Q28569034 |
| | Psychoproteomic analysis of rat cortex following acute methamphetamine exposure | Q28581652 |
| | Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment | Q28583481 |
| | Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo | Q28585083 |
| | Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling | Q28588350 |
| | The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 |
| | AKAP signalling complexes: focal points in space and time | Q29618533 |
| | Protein oxidation in aging, disease, and oxidative stress | Q29619442 |
| | Tyrosine phosphorylation of synapsin I by Src regulates synaptic-vesicle trafficking | Q30156829 |
| | Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration | Q30504753 |
| | Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry | Q30757635 |
| | MDMA: A Review of Epidemiological Data | Q30784888 |
| | The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification | Q31046463 |
| | Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. | Q32068809 |
| | Microarray studies of psychostimulant-induced changes in gene expression | Q33214334 |
| | Mass spectrometry and protein analysis | Q33239890 |
| | Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims | Q33262178 |
| | Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization | Q33277865 |
| | Quinone electrophiles selectively adduct "electrophile binding motifs" within cytochrome c. | Q33297886 |
| | Integrating shotgun proteomics and mRNA expression data to improve protein identification | Q33421651 |
| | Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction | Q33434961 |
| | Modeling substance abuse for applications in proteomics | Q33522646 |
| | Perspectives of a systems biology of the synapse: how to transform an indefinite data space into a model? | Q33580350 |
| | Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates | Q33608570 |
| | Assessment of genome and proteome profiles in cocaine abuse | Q33722792 |
| | AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis | Q33871972 |
| | A mammalian organelle map by protein correlation profiling | Q33995084 |
| | A comparison of selected mRNA and protein abundances in human liver | Q34064644 |
| | Neuronal apoptosis inhibitory protein: Structural requirements for hippocalcin binding and effects on survival of NGF-dependent sympathetic neurons. | Q34160270 |
| | The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q34215236 |
| | Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells. | Q34303809 |
| | Distribution measurements of 3,4-methylenedioxymethamphetamine and its metabolites in organs by matrix-assisted laser desorption/ionization imaging mass spectrometry using an automatic matrix spraying system with an air brush and a turntable | Q34366732 |
| | Cocaine-induced expression changes of axon guidance molecules in the adult rat brain | Q34390929 |
| | Acute liver damage and ecstasy ingestion | Q34409489 |
| | Neurocognitive effects of methamphetamine: a critical review and meta-analysis | Q34662295 |
| | Apoptosis-an introduction | Q35206030 |
| | Ecstasy: pharmacodynamic and pharmacokinetic interactions | Q35622273 |
| | Ecstasy and gateway drugs: initiating the use of ecstasy and other drugs | Q35749847 |
| | Proteomics in postgenomic neuroscience: the end of the beginning. | Q35758816 |
| | Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver | Q35909784 |
| | Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity | Q36028480 |
| | Stimulation of human thyroid growth via the inhibitory guanine nucleotide binding (G) protein Gi: constitutive expression of the G-protein alpha subunit Gi alpha-1 in autonomous adenoma | Q36117740 |
| | Ion channel functional candidate genes in multigenic neuropsychiatric disease | Q36404520 |
| | Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin | Q36408206 |
| | Shotgun proteomics using the iTRAQ isobaric tags | Q36505967 |
| | Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis | Q36524814 |
| | Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers | Q36629050 |
| | Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry | Q36682379 |
| | Use of proteomics for the identification of novel drug targets in brain diseases | Q36785927 |
| | Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms | Q36797987 |
| | Methamphetamine causes microglial activation in the brains of human abusers. | Q36801473 |
| | The role of electrophoresis in disease biomarker discovery | Q36822170 |
| | Administration of the calcineurin inhibitor cyclosporine modulates cocaine-induced locomotor activity in rats | Q36952711 |
| | Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver | Q36990037 |
| | A new strategy for gene targeting and functional proteomics using the DT40 cell line | Q37197853 |
| | Persistent proteomic alterations in the medial prefrontal cortex with abstinence from cocaine self-administration | Q37343024 |
| | Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats. | Q37349744 |
| | The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice | Q37396386 |
| | Common variants in polygenic schizophrenia. | Q37604461 |
| | Strain-specific proteogenomics accelerates the discovery of natural products via their biosynthetic pathways | Q37625389 |
| | Proteomic research in psychiatry | Q37689362 |
| | Substance use disorders and psychiatric comorbidity in mid and later life: a review | Q37719528 |
| P921 | main subject | substance abuse | Q3184856 |
| | neuroproteomics | Q7002580 |
| P304 | page(s) | 38-52 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Translational proteomics | Q27725679 |
| P1476 | title | Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA | |
| P478 | volume | 3 | |